EX-2.1
from 8-K
107 pages
[***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. Agreement and Plan of Merger Among: Century Therapeutics, Inc., a Delaware Corporation; Clarent Intermediate Sub, Inc., a Delaware Corporation; Clarent Merger Sub, Inc., a Delaware Corporation; Clade Therapeutics, Inc., a Delaware Corporation; and Fortis Advisors LLC, as the Securityholders’ Agent Dated as of April 11, 2024
12/34/56
